endocrinology
Bone health

No bisphosphonate benefit beyond five years: study

The issue of bisphosphonate holidays has again been raised by US researchers who found that therapy beyond five years was not associated with lower risk of hip fracture in postmenopausal women. In an observational study involving 29,685 women who took bisphosphonates for five years, there was no difference in hip fracture risk among those who ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic